Harmony Net Interest Income from 2010 to 2026

HRMY Stock  USD 36.69  0.78  2.17%   
Harmony Biosciences Net Interest Income yearly trend continues to be fairly stable with very little volatility. Net Interest Income is likely to outpace its year average in 2026. Net Interest Income is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. View All Fundamentals
 
Net Interest Income  
First Reported
2019-06-30
Previous Quarter
1.6 M
Current Value
2.1 M
Quarterly Volatility
M
 
Covid
Check Harmony Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harmony Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 55.9 M, Net Interest Income of 988.5 K or Depreciation And Amortization of 16.4 M, as well as many indicators such as Price To Sales Ratio of 2.99, Dividend Yield of 0.0 or PTB Ratio of 2.81. Harmony financial statements analysis is a perfect complement when working with Harmony Biosciences Valuation or Volatility modules.
  
Build AI portfolio with Harmony Stock
Check out the analysis of Harmony Biosciences Correlation against competitors.

Latest Harmony Biosciences' Net Interest Income Growth Pattern

Below is the plot of the Net Interest Income of Harmony Biosciences Holdings over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Harmony Biosciences' Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harmony Biosciences' overall financial position and show how it may be relating to other accounts over time.
Net Interest Income10 Years Trend
Slightly volatile
   Net Interest Income   
       Timeline  

Harmony Net Interest Income Regression Statistics

Arithmetic Mean(4,058,655)
Coefficient Of Variation(241.68)
Mean Deviation7,711,615
Median1,541,000
Standard Deviation9,809,021
Sample Variance96.2T
Range29.8M
R-Value(0.37)
Mean Square Error88.8T
R-Squared0.14
Significance0.15
Slope(714,097)
Total Sum of Squares1539.5T

Harmony Net Interest Income History

2026988.5 K
2025941.4 K
2024M
2023-11.9 M
2022-15.7 M
2021-24 M
2020-28.2 M

About Harmony Biosciences Financial Statements

Harmony Biosciences investors use historical fundamental indicators, such as Harmony Biosciences' Net Interest Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Harmony Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Interest Income941.4 K988.5 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Harmony Stock Analysis

When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.